Maple Capital Management Inc. Purchases 1,839 Shares of UnitedHealth Group Incorporated (NYSE:UNH)

Maple Capital Management Inc. increased its position in UnitedHealth Group Incorporated (NYSE:UNH) by 2.8% in the 3rd quarter, according to the company in its most recent filing with the SEC. The fund owned 66,666 shares of the healthcare conglomerate’s stock after acquiring an additional 1,839 shares during the quarter. UnitedHealth Group comprises 3.0% of Maple Capital Management Inc.’s investment portfolio, making the stock its 12th largest holding. Maple Capital Management Inc.’s holdings in UnitedHealth Group were worth $38,978,000 at the end of the most recent quarter.

A number of other institutional investors and hedge funds have also recently added to or reduced their stakes in the business. Kathleen S. Wright Associates Inc. purchased a new position in UnitedHealth Group during the 3rd quarter valued at about $27,000. Global Wealth Strategies & Associates increased its holdings in UnitedHealth Group by 152.4% during the 3rd quarter. Global Wealth Strategies & Associates now owns 53 shares of the healthcare conglomerate’s stock worth $31,000 after acquiring an additional 32 shares during the period. Macroview Investment Management LLC boosted its holdings in UnitedHealth Group by 671.4% in the 2nd quarter. Macroview Investment Management LLC now owns 54 shares of the healthcare conglomerate’s stock valued at $28,000 after purchasing an additional 47 shares during the period. West Financial Advisors LLC bought a new position in shares of UnitedHealth Group in the third quarter worth $32,000. Finally, Delos Wealth Advisors LLC boosted its stake in UnitedHealth Group by 757.1% during the first quarter. Delos Wealth Advisors LLC now owns 60 shares of the healthcare conglomerate’s stock valued at $30,000 after buying an additional 53 shares during the period. Institutional investors own 87.86% of the company’s stock.

UnitedHealth Group Trading Up 0.3 %

UNH opened at $571.46 on Tuesday. The company has a debt-to-equity ratio of 0.74, a current ratio of 0.91 and a quick ratio of 0.88. UnitedHealth Group Incorporated has a one year low of $436.38 and a one year high of $608.63. The firm has a market capitalization of $527.70 billion, a price-to-earnings ratio of 37.23, a PEG ratio of 1.67 and a beta of 0.58. The business has a 50 day simple moving average of $584.55 and a two-hundred day simple moving average of $535.49.

UnitedHealth Group (NYSE:UNH) last issued its quarterly earnings data on Tuesday, October 15th. The healthcare conglomerate reported $7.15 earnings per share (EPS) for the quarter, beating analysts’ consensus estimates of $7.00 by $0.15. The business had revenue of $100.82 billion for the quarter, compared to the consensus estimate of $99.14 billion. UnitedHealth Group had a net margin of 3.63% and a return on equity of 26.37%. The company’s quarterly revenue was up 9.2% compared to the same quarter last year. During the same period in the previous year, the firm earned $6.56 EPS. Analysts predict that UnitedHealth Group Incorporated will post 27.61 EPS for the current year.

UnitedHealth Group Dividend Announcement

The company also recently announced a quarterly dividend, which was paid on Tuesday, September 24th. Stockholders of record on Monday, September 16th were paid a $2.10 dividend. This represents a $8.40 dividend on an annualized basis and a dividend yield of 1.47%. The ex-dividend date of this dividend was Monday, September 16th. UnitedHealth Group’s payout ratio is presently 54.72%.

Analysts Set New Price Targets

UNH has been the subject of a number of research analyst reports. Bank of America dropped their price target on UnitedHealth Group from $675.00 to $650.00 and set a “buy” rating for the company in a research report on Wednesday, October 16th. StockNews.com raised shares of UnitedHealth Group from a “hold” rating to a “buy” rating in a report on Wednesday, October 16th. Barclays increased their target price on UnitedHealth Group from $560.00 to $604.00 and gave the company an “overweight” rating in a research note on Wednesday, July 17th. Stephens cut their price objective on UnitedHealth Group from $632.00 to $605.00 and set an “overweight” rating for the company in a report on Wednesday, October 16th. Finally, Truist Financial restated a “buy” rating and issued a $625.00 target price (down previously from $640.00) on shares of UnitedHealth Group in a research report on Wednesday, October 16th. Three equities research analysts have rated the stock with a hold rating, eighteen have assigned a buy rating and two have assigned a strong buy rating to the stock. Based on data from MarketBeat.com, the company currently has an average rating of “Moderate Buy” and an average price target of $615.58.

About UnitedHealth Group

UnitedHealth Group Incorporated operates as a diversified health care company in the United States. The company operates through four segments: UnitedHealthcare, Optum Health, Optum Insight, and Optum Rx. The UnitedHealthcare segment offers consumer-oriented health benefit plans and services for national employers, public sector employers, mid-sized employers, small businesses, and individuals; health care coverage, and health and well-being services to individuals age 50 and older addressing their needs; Medicaid plans, children's health insurance and health care programs; and health and dental benefits, and hospital and clinical services, as well as health care benefits products and services to state programs caring for the economically disadvantaged, medically underserved, and those without the benefit of employer-funded health care coverage.